SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Corporate Vision (CVIA) -- Ignore unavailable to you. Want to Upgrade?


To: Milk who wrote (2475)3/17/1998 6:02:00 PM
From: Milk  Read Replies (3) | Respond to of 6654
 
TYPE:ÿÿ8-K
ÿSEQUENCE:ÿÿ1

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report(Date of earliest event reported) Dec 15,1997

Corporate Vision, Inc
(Exact Name of Registrant as Specified in Charter)

Oklahoma 0-18824 73-1380820
(State of (Commission (IRS Employer
Incorporation) File Number) Identification No.)

6202 South Lewis, Suite A, Tulsa, Ok 74136
(Address of Principal Executive Offices)

Registrant's telephone number, including area code (918) 747-2842



8908 South Yale, Suite 360 - Tulsa, Ok 74134
(Former Address, If Changed Since Last Report)



ITEM 5. OTHER EVENTS

During December, 1997 the company received $500,000 net proceeds
from a Regulation S private placement offering of $500,000 8%
convertible debentures with due dates in January and February,
1998. The notes are convertible at the option of the holder into
common stock of the Company at 65% of the closing bid price of the
common Stock for the business day immediately preceding the date of
receipt by the Company of the holder's notice of conversion.

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.

Corporate Vision, Inc

By: Jack Arnold
Jack Arnold, President, CEO

March 13, 1998